Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal pemetrexed for gastric cancer with malignant ascites
ChiCTR-IPR-15006200Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pemetrexed in gastric cancer (GC) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Ascites level and Progression-free survival. Started Apr 2015; status: recruiting.
02
Drugs
pemetrexed
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-IPR-15006200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006200.